Atlas Venture Associates XI, LLC, 10% Owner at Day One Biopharmaceuticals, Inc. (DAWN), bought 8,011,380 shares at $16.00 ($4.0M) on 2021-06-01, disclosed to the SEC on 2021-06-02.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 7,761,380 | $0 | 0.0% |
| 2 | $16.00 | 250,000 | $4.0M | 100.0% |
| Total | $0.50 avg | 8,011,380 | $4.0M | 100% |
| Filing → |
| DAWN | BUY | 2022-06-22 | $11.5M | — | Filing → |